secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2023-07-10T23:59:59+00:00
Accession:  0001193125-23-184765
Event type: other_material
Sentiment:  negative
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD dismisses Grant Thornton, engages BPB; prior reports had going concern note
--------------------------------------------------------------------------------

- Grant Thornton dismissed as independent auditor on July 7, 2023; Berkowitz Pollack Brant appointed.
- GT's reports for FY 2022 and 2021 included an explanatory paragraph on going concern uncertainty.
- No disagreements with GT on accounting principles or audit scope; no reportable events occurred.
- Audit change resulted from a request for proposal process.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000119312523184765/0001193125-23-184765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000119312523184765/d523471d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-184765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer